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Protein arginylation and arginine methylation are two
posttranslational modifications of emerging impor-
tance that involve Arg residues and their modifica-
tions. To test a hypothesis that posttranslationally
added arginines can be methylated, we used high-
precision mass spectrometry and metabolic labeling
to find whether posttranslationally added arginines
can serve as methylation sites. We identified a
number of proteins in vivo, on which posttranslation-
ally added Arg have undergone mono- and dime-
thylation. This double modification predominantly
affects the chromatin-containing nuclear fraction
and likely plays an important regulatory role in
chromatin-associated proteins. Moreover, inhibition
of arginylation and Arg methylation results in a
significant reduction of the nucleus size in cultured
cells, suggesting changes in chromatin compaction
and nuclear architecture. Our findings suggest a
functional link between protein regulation by arginy-
lation and methylation that affects nuclear structure
in vivo.
INTRODUCTION
Posttranslational modifications regulate the majority of protein
functions and physiological pathways and add an extra level of
complexity to the structural and functional diversity of the pro-
teome. Many modifications that have been discovered decades
ago are now coming into the spotlight, as new studies show
evidence of their major physiological role. One suchmodification
is arginine methylation, recently demonstrated to regulate
a variety of processes, including protein-protein interactions,
RNA binding, transcription, signal transduction, and DNA repair
(for review see Bedford and Richard, 2005). Another modifica-
tion, whose role has emerged in recent studies, is arginyla-
tion—posttranslational addition of Arg onto proteins that has
been shown to affect many proteins in vivo (Wong et al., 2007)
and modulate critical physiological processes such as cellChemistry & Biology 18, 1369–137motility and cardiovascular development (Karakozova et al.,
2006; Kwon et al., 2002).
Although no link between the two modifications has been
previously suggested, a natural question arises of whether post-
translationally added Arg can serve as a site for the action of
protein Arg-methyltransferases. Here, we addressed this ques-
tion by examining posttranslational arginylation and methylation
in subcellular fractions and found that posttranslationally arginy-
lated proteins can be methylated on added arginines and that
this double modification occurs with higher frequency in the
nuclear compared to the cytosolic proteins, due likely to the
higher nuclear activity of arginylation and methylation enzymes.
The identity of the modified proteins and the location of arginyla-
tion and arginylation/methylation sites suggest that these modi-
fications in the nucleus are involved in the global regulation of
chromatin structure, alternative splicing, and gene expression.
Furthermore, our studies in cultured cells showed that inhibition
of arginylation and/or Arg methylation results in a significant
reduction of the nuclear size, suggesting that these two modifi-
cations are essential for maintaining normal chromatin compac-
tion and nuclear architecture. Our results are the first demonstra-
tion of posttranslational modifications doubled up on the same
sites to regulate an important subset of proteins in vivo.
RESULTS
Posttranslationally Added Arginines Can Be Methylated
In Vivo
To address the possible relationship between posttranslational
arginylation and Arg methylation, we examined the samples
isolated from subcellular fractions of mouse tissues and cultured
cells by high-precision mass spectrometry to find out whether
any of the posttranslationally added Arg are found in the methyl-
ated state (i.e., contain a mass addition of Arg [+156.1011] with
an extra mass of either one [+14.0157] or two [+28.0314] methyl
groups).
Analysis of the cytosolic fractions derived from cultured
embryonic fibroblasts and mouse heart tissue revealed two
peptides in different samples, in which an internal site within the
molecule containeddimethylatedArg (massaddition+184.1325).
One peptide belongs to a-cardiac actin (identified in a 2D gel
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Figure 1. MS/MS Spectrum of the Experimentally Identified Arginylated Methylated Peptide Matches a Synthetic Peptide Standard of the
Same Structure
MS/MS spectra of the experimentally identified dimethyl-arginylated actin peptide (NP-033736.1) (left, Natural peptide) and synthetic standard peptide
containing N-terminal dimethylated Arg (right, dimethyl groups in both are denoted with double stars). Peptide sequences and b and y ion masses are shown
on the top right for each spectrum and in the tables underneath.
See Table S1 for the search parameters. See also Figure S1.
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Arginylation Meets Methylationand one is common between heat shock proteins 90 and 84b
(identified by six different scans in a protein sample isolated by
immunoaffinity chromatography with N-terminal Arg-specific
antibody; Wong et al. [2007]; from mouse heart tissue) (Figure 1;
see Figure S1 and Table S1 available online).
To confirm that the identified modification indeed represents
Arg methylation and does not arise from an ambiguity that
mimics a mass addition of +184.1325, we synthesized both
peptides with a dimethyl-Arg residue in the N-terminal position,
and compared the tandem mass spectra of these peptides with
the tandemmass spectra of the arginylated/methylated peptides
identified in the real sample. We found that the spectra between
the standard peptides and the in vivo samples matched, both in
the precursor masses and in the fragmentation patterns (see Fig-
ure 1 and Figure S1 for mass spectra and Table S1 for the pre-
cursor and ion fragment masses), confirming that the peptides
identified by our analysis were truly arginylated/methylated.1370 Chemistry & Biology 18, 1369–1378, November 23, 2011 ª2011Posttranslational Arginylation andMethylation Regulate
Nuclear and Chromatin-Bound Proteins
Because Arg methylation is known to affect a large number of
chromatin-associated proteins, it appears likely that if posttrans-
lational arginylation and methylation indeed have a functional
relationship, arginylation should also prominently affect chro-
matin-associated proteins, and such proteins could then be
methylated on the added Arg to a higher extent than proteins
in the cytosol. To test this hypothesis, we performed meta-
bolic-labeling assays to compare the overall patterns of post-
translational Arg andmethyl incorporation in different subcellular
fractions (Figure 2A), by incubating cycloheximide and chloram-
phenicol-treated cells (to inhibit cotranslational incorporation of
amino acids) with radioactively labeled 3H-Arg or 3H-Met (the
source of methyl groups). As a negative control in these experi-
ments, we used Arginyl-tRNA-protein transferase 1 knockout
(Ate1 KO) fibroblasts, in which arginylation does not occur, andElsevier Ltd All rights reserved
Figure 2. Arg and Methyl Group Incorporation into Different Subcel-
lular Fractions
(A) Western blot of the cytosolic and nuclear fractions with the cytoplasmic
marker tubulin (left) and the ER marker cytochrome P450 oxidoreductase
confirms that purified nuclear fractions are devoid of cytosolic and ER
contaminants. All the fractions for western blotting were normalized by total
protein amount.
(B) In vivo incorporation of 3H-Arg into cycloheximide and chloramphenicol-
treated WT and Ate1 KO cells presented as counts per minute (cpm)/micro-
gram (mg) of protein. Error bars represent SEM (n = 4). Chromatin fraction
p value is 0.0874.
(C) In vivo incorporation of 3H-Met (the source of the methyl groups) into
cycloheximide/chloramphenicol-treated WT and Ate1 KO cells presented as
cpm/mg of protein. Error bars represent SEM (n = 3). Cytosol and chromatin
fraction p values are 0.016 and 0.1, respectively.
See also Figures S2 and S3.
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Arginylation Meets Methylationprotein methylation happens without the contribution of post-
translationally added Arg.
During both treatments, residual incorporation of radioactively
labeled amino acids occurred due to incompletely inhibited
protein synthesis, producing a background level of radioactive
label incorporation (as seen from the Ate1 KO bars in Figure 2B).
Surprisingly, Arg incorporation into the cytosolic and nucleosolic
protein fractions in wild-type (WT) cells did not exceed this back-
ground and did not significantly differ from that in the Ate1 KO,
suggesting that the overall stable level of posttranslational argi-
nylation under these conditions is below the detection level for
this assay. However, the amount of Arg incorporated into the
chromatin-associated fraction inWT cells significantly exceededChemistry & Biology 18, 1369–137that in the Ate1 KO (the rightmost set of bars in Figure 2B), indi-
cating that posttranslational arginylation level is very significant
in the chromatin fraction. Control experiments using cells
without cycloheximide treatment (that incorporate Arg both
during translation and posttranslationally) showed that such
incorporation is also comparatively higher in the nucleosolic
and chromatin fractions of WT cells, compared to the cytosolic
protein fraction and to the Ate1 KO cells (Figure S3A).
Comparison of methylation levels in different subcellular frac-
tions fromWT and arginylation KO cells revealed the same trend
(Figure 2C). Although the nucleosol fraction from WT and Ate1
KOcells had a similar amount of methyl group incorporation after
4 hr of metabolic labeling, the chromatin fraction in Ate1 KO cells
had significantly less methylation than WT. At the same time
methylation levels in the cytosol in Ate1 KO cells were higher
than in WT cells, suggesting that absence of arginylation may
lead to specific changes in protein Arg methylation in the cells.
To test this and to evaluate the total methyl-Arg content in the
protein-incorporated and free amino acid state, we performed
amino acid analysis to detect methylated Arg derivatives in
hydrolyzed total protein samples and in protein-free low molec-
ular weight pools obtained from total cell lysates containing both
the nuclear and the cytosolic fraction. We found that total meth-
ylation, as well as the amount of methylated Arg both in the total
protein and in the free amino acid pool, was higher in Ate1 KO
than in WT (Figure S2), suggesting that in these cells the overall
Arg methylation was increased via arginylation-independent
mechanisms. Given these results, the increased arginylation
and methylation in the chromatin fraction of WT appear even
more striking and strongly suggest that arginylation-dependent
methylation contributes significantly to the overall methyl incor-
poration specifically in the chromatin. Control experiments sug-
gested that this methyl-arginylation was likely not mediated by
arginyltransferase itself because purified ATE1 mixed in vitro
with methylated Arg, tRNA, and Arg-tRNA-synthetase was
unable to transfer methylated Arg onto the test substrate.
Control experiments also suggested that inhibition of Arg meth-
ylation using the commercially available protein arginine methyl-
transferase inhibitor AMI-1 resulted in a reduction of methyl
incorporation into the chromatin proteins in WT cells, but not in
the Ate1 KO cells, suggesting that only the Arg-methyltrans-
ferases specifically affected by this inhibitor are likely respon-
sible for arginylation-dependent Arg methylation, whereas the
overall increase of Arg methylation in Ate1 KO is likely mediated
by other types of Arg methyltransferases. In agreement with this,
AMI-1 treatment had negligible and somewhat opposite effects
on the cytosolic and nucleosolic Arg methylation in WT and
Ate1 KO cells (Figure S3B). Overall, these data suggest that
posttranslational arginylation/methylation requires both the
activity of arginyltransferase and the activity of specific type(s)
of Arg-methyltransferase(s).
To test whether the higher incorporation of Arg into the nuclear
proteins is related to the higher levels and/or activity of nuclear
ATE1, we first detected the levels of ATE1 in the cytosol and
the nucleus by immunoblotting and found that whereas ATE1
is present in both subcellular fractions, its level in the nucleus
is significantly lower than that in the cytosol (inset in Figure 3A).
We then used the cytosolic and the nuclear fractions in an in vitro
arginylation assay and found that in the nuclear fraction,8, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1371
Figure 3. ATE1 Is Less Abundant but More Active in the Nucleus
(A) Inset is a western blot showing ATE1 levels in the cytosol and nucleus in the samples loaded at the equal protein level. The chart shows 3H-Arg incorporation by
endogenous ATE1 into cellular proteins in cytosolic and nuclear extracts at different time points. Error bars represent SEM (n = 2).
(B) The same curves as in (A) normalized to the ATE1 levels detected by the western blots shown in (A), inset. ATE1 activity per molecule is significantly higher in
the nucleus than in the cytosol.
See also Figure S4.
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Arginylation Meets Methylationarginylation activity was higher than in the cytosol (Figure 3A).
When normalized to the comparative ATE1 levels in the two
fractions, this activity was several times higher in the nucleus
compared to the cytosol (Figure 3B). Control experiments
showed that RNase A treatment abolished this Arg incorporation
activity both in the nucleus and in the cytosol, confirming that the
activity was RNA dependent (Figure S4). Therefore, increased
arginylation of nuclear proteins is associated with a significantly
higher arginyltransferase activity in the nucleus compared to the
cytosol.
Identification of Arginylated and Arginylated/
Methylated Proteins in the Nucleus
To identify proteins that are arginylated and arginylated/methyl-
ated in the nuclear subfractions, we analyzed total proteins
found in the fractionated nuclear samples from mouse embry-
onic fibroblasts (MEFs) by mass spectrometry. This analysis
revealed a large number of proteins that were arginylated in
the nuclear subfractions. A significant subset of these proteins
was found to contain posttranslationally added methyl-Arg, sug-
gesting that these proteins have undergone methylation upon
arginylation (see Tables 1 and 2 for the lists of proteins, and
Datasets S1 and S2 for the mass spectra of arginylated/
methylated and arginylated peptides, respectively). Some of
these proteins contained dimethylated Arg, similarly to those
previously identified in the cytosol. Others contained monome-
thylated Arg, suggesting that methylation of posttranslationally
added Arg occurs in steps and is likely mediated by the same
enzymes as regular Arg methylation. Remarkably, these proteins
were identified without any special enrichment procedures in the
total nuclear pool, suggesting that the extent of arginylation and
arginylation/methylation on these proteins is relatively high.
Overall, the arginylated and arginylated/methylated proteins
identified by this analysis fell into distinct functional groups. A
prominent subset of these proteins included histones, which
were arginylated and in some cases further methylated on the
sites involved in DNA binding, ion interaction, and association
with other histones in the nucleosome complex (Figure 4A). On
these proteins, arginylated sites were identified in multiple scans1372 Chemistry & Biology 18, 1369–1378, November 23, 2011 ª2011in different analyzed subsets, suggesting that the overall abun-
dance of the arginylated form of these proteins was relatively
high. Another subset of arginylated proteins has roles in gene
expression and RNA splicing, including RNA-binding proteins
and related factors. Although, similar to the previous studies
(Wong et al., 2007), no arginylation consensus was found at or
around these sites, a Lys residue was prevalent in the (1) posi-
tion to the arginylated site. This finding suggests that in the
nucleus, unlike in the cytosol, recognition of proteins by the argi-
nylation machinery may be mediated by Lys-containing primary
sequence motifs. Structural analysis using the 3D structures
available in the PDB database for these proteins or their close
homologs revealed that in all cases arginylation sites were
located on the protein surface (Figure 4; Figure S5) and in
many cases fell onto functionally significant regulatory regions
of these proteins. Structural modeling of the arginylated histone
proteins and the nucleosome indicated that some of the added
Arg and methyl-Arg have a distance of 5–7 A˚ from the nearest
phosphate in the DNA backbone that, given the opposite
charges in these groups, can potentially facilitate the interaction
of the histones, with DNA (Figure 4A). These results confirm that
arginylation and arginylation/methylation occur to a significant
extent in the nucleus compared to the cytosol, and that these
modifications in the nucleus likely play an important regulatory
role.
Arginylation/Methylation Regulates Nuclear Size
in Cultured Cells
To assess the biological role of arginylation/methylation of chro-
matin proteins, we analyzed the identity of these proteins (Tables
1 and 2) and noticed that a large fraction of these proteins had
prominent roles in DNA compaction and architecture. To test
the hypothesis that arginylation/methylation regulates nuclear
architecture, we compared the nucleus size in cultured WT and
Ate1 KO MEFs and found that Ate1 KO nuclei were 20%
smaller compared to WT nuclei (Figures 5A and 5B). Strikingly,
treatment of WT and Ate1 KO cells with AMI-1 reduced the
nuclear size of the WT MEFs to the same extent (by approxi-
mately 20%), without affecting the nuclear size in Ate1 KO cellsElsevier Ltd All rights reserved







AAA37866 HSP90-a/HSP84b S587 DMA Cytosol Heat shock
NP_033736.1 Actin, a skeletal muscle I87 DMA Cytosol Actin cytoskeleton
NP_058557.2 PDZ and LIM domain protein 1 I30 MMA Nucleosol Actin cytoskeleton
NP_062752.2 Zinc finger and BTB domain
containing 20 isoform L
I69 MMA Nucleosol Transcriptional repressor
NP_001104761.1 Cytoplasmic activation/
proliferation-
associated protein 1 isoform c
L170 DMA Nucleosol Cell proliferation, translation
regulation, RNA binding
NP_598432 Splicing factor U2AF 65 kDa subunit G248 MMA Nucleosol Pre-mRNA splicing, 30 end
mRNA processing
NP_035561.1 116 kDa U5 sn RNP component
isoform a
E689 DMA Nucleosol Pre-mRNA splicing
NP_598841.1 Filamin B S1911 MMA Chromatin Actin cytoskeleton
CAM16973.1 Spectrin b-2 E741 MMA Chromatin Actin cytoskeleton
NP_835509.2 Histone H2B F K47 MMA Chromatin Chromatin structure and organization
NP_033736.1 Actin, a skeletal muscle N299 MMA Chromatin Actin cytoskeleton
NP_032017.2 Fibrillarin Q160 MMA Chromatin snoRNP particle component,
pre-rRNA processing, pre-rRNA
methylation, ribosome assembly
NP_035897.2 Zinc finger RNA-binding protein A444 DMA Chromatin RNA transport and localization
See Table S2 for the search parameters and peptide sequences, and see Figure 1, Figure S1, and Dataset S1 for the corresponding mass spectra.
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Arginylation Meets Methylation(Figures 5A and 5B). Thus, inhibition of both arginylation and Arg
methylation leads to exactly the same effect on the nuclear size,
clearly indicating that arginylation combined with methylation
regulates nuclear size in vivo. Because nuclear size can change
due to alteration in chromatin compaction or other structural
change in nucleus, the exact mechanism of arginylation/
methylation-mediated regulation of nuclear size remains to be
investigated.
DISCUSSION
This work is the first demonstration that two posttranslational
modifications can affect the same sites in a protein, and the
first comprehensive analysis of arginylation in the nucleus
that reveals the identity of a significant number of previously
unknown protein arginylation targets and outlines a likely func-
tion for protein arginylation in chromatin structure and gene
expression. Our result that ATE1 is less abundant and more
active in the nucleus suggests that this enzyme undergoes an
additional level of regulation that could increase or reduce its
activity dependent on its intracellular localization. Such regula-
tion could be achieved by modulating the interaction of ATE1
with different binding partners in the cytoplasm and the nucleus
that may form either activatory or inhibitory complexes with this
enzyme and/or regulate its activity by changing its conformation
or posttranslationally modified state. Different chemical environ-
ments in these two intracellular compartments may also play
a role, by creating favorable or unfavorable ionic conditions for
arginylation.
It has been previously shown that some ATE1 isoforms
showed preferential nuclear localization under certain condi-Chemistry & Biology 18, 1369–137tions, suggesting that this localization depends on the cell’s
physiological state (Kwon et al., 1999; Rai and Kashina, 2005;
Wang et al., 2011). It is possible that higher arginylation activity
in the nucleus could be necessary because of the existence of
a higher number and/or amount of natural substrates of ATE1
in the nucleus. It was previously found that partially purified
ATE1 preparation can arginylate nuclear proteins in vitro (Kaji,
1976). Our data demonstrate for the first time that ATE1 prefer-
entially arginylates nuclear proteins in vivo and that the activity
of this enzyme can be differentially regulated in different intracel-
lular compartments.
Many of the proteins identified in the cytosolic and chromatin
fractions have a demonstrated role in the corresponding
compartments, such as HSP90 in the cytosol, and DNA- and
RNA-binding proteins involved in chromatin structure, gene
expression, and RNA processing in vivo. For such proteins,
regulation by arginylation with or without subsequent methyla-
tion can conceivably facilitate their structural interactions and
affect their in vivo functions. For nucleic acid-binding proteins,
these modifications likely affect their ability to interact with the
nucleic acids (which should be facilitated by the addition of
the positively charged Arg), or other proteins, which could be
repelled or attracted by the chemical groups on the matching
surfaces of the interaction partners. However, a number of
proteins found in the nucleosolic and chromatin fractions have
been previously characterized as cytoplasmic proteins. For
some of those, including actin, GAPDH, filamin, and spectrin,
recent data demonstrate their involvement in gene expression
and transcriptional regulation (Grummt, 2006; Loy et al., 2003;
Sawa et al., 1997; Tang et al., 2003). It is likely that arginylation
and arginylation/methylation of these proteins in the nucleus8, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1373







NP_034928.1 Macrophage migration inhibitory factor A35 Nucleosol Proinflammatory cytokine
CAM24508.1 Far upstream element binding protein 3 I111 Nucleosol ssDNA and RNA binding, transcriptional
and posttranscriptional regulation
P11499.2 HSP 90b L439 Nucleosol Heat shock
NP_034368.2 Bromodomain-containing protein 2
isoform a
L10 Nucleosol Transcriptional regulation, chromatin remodeling,
signal transduction, nuclear kinase




Glycolysis, transcription activation, initiation of
apoptosis, and ER to Golgi vesicle transport.
NP_035931.1 Craniofacial development protein 1 K104 Nucleosol Transcriptional developmental signaling
CAI24328.1 RAB34 D75 Nucleosol Lysosomal positioning, protein transport
and secretion
NP_034063.1 Collagen a-1(VI) chain precursor E576 Nucleosol Extracellular matrix
NP_084206.1 Hypothetical protein LOC77574 G633 Nucleosol Unknown
NP_663600.2 Eukaryotic translation initiation factor 4B G138 Nucleosol Translation
BAC36440.1 Histone H2B homolog A59 Chromatin Chromatin structure and organization
NP_783597.2 Histone H2B type 2-B Q48; A59 Chromatin Chromatin structure and organization
XP_981474.1 Histone H4 T136; V116 Chromatin Chromatin structure and organization
AAA37763.1 Histone H2A.1 S41 Chromatin Chromatin structure and organization
EDK99240.1 Ribophorin I, isoform CRA_a V468 Chromatin N-glycosylation, ER chaperone
NP_031419.1 Actin, b D51 Chromatin Actin cytoskeleton, transcriptional regulation
XP_001476183.1 Similar to ribosomal protein L23a L140 Chromatin Ribosomal organization
NP_035831.2 Vimentin V224 Chromatin Intermediate filament, cytoskeleton
NP_080447.1 Nuclear valosin-containing protein-like T628 Chromatin Nuclear ATPase
See Table S2 for the search parameters and peptide sequences and Dataset S2 for the corresponding mass spectra.
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Arginylation Meets Methylationcan facilitate this specific function. For others, such as collagen,
no such function has been previously demonstrated. It
is possible that their interaction with the chromatin is a non-
specific effect, resulting from the presence of the surface Arg
residues that may induce their interaction with DNA after cell
and nuclear lysis. However, it is also possible that their presence
in the nuclear fractions found in this study reflects their previ-
ously unknown function in the chromatin and/or transcriptional
control.
Structural and sequence analysis shows that arginylated sites
for most of the identified proteins are located in the middle of
their polypeptide chains, in conserved domains predicted to
affect key molecular interactions (Figure 4; Figure S5). It has
been previously found that for many arginylated proteins, sites
for posttranslational addition of Arg are located in the middle of
the polypeptides, far away from the N terminus, suggesting
a novel regulatory mechanism that couples arginylation with
partial regulatory proteolysis without disrupting the protein’s
quaternary structure (Wong et al., 2007). In agreement with
this, all the available structural data presented in our current
study (Figures 4; Figure S4) show that arginylated sites are
exposed within the structurally important conserved domains
on the protein surface, suggesting that arginylation on these
sites affects fully synthesized and folded proteins and plays an
important regulatory role. The measured distances of the added
Arg or methyl-Arg residues in histones to the phosphate groups
in the DNA backbone are particularly encouraging, because1374 Chemistry & Biology 18, 1369–1378, November 23, 2011 ª2011these distances with the added Arg are short enough to signifi-
cantly affect the interaction of histones with DNA, and thus,
can affect DNA packaging and/or transcriptional regulation.
Conceivably, addition of methyl groups onto Arg in these posi-
tions should stabilize the arginylation sites and ensure their
longer-term action in the nucleosome. Further studies of the indi-
vidual arginylation sites identified in this study will reveal the
functional significance of their regulation by arginylation and
advance the knowledge about this poorly understood posttrans-
lational modification to the next level of understanding.
Our finding that posttranslationally added Arg can be methyl-
ated constitutes a proof of principle and the first demonstration
that posttranslational modifications can double on the same
sites within the proteins. It has been previously shown that a
negative posttranslational regulation of methylation by phos-
phorylation can occur by modifying the neighboring residues
to change the charge and conformation of the methylation
sites (Bedford and Richard, 2005). We show for the first time
a positive regulation by a posttranslational modification that
can facilitate methylation by creating an acceptor site for methyl
groups. Although many of the functions of such double modifi-
cations remain to be determined, our study shows a clear corre-
lation between arginylation/methylation and the nuclear size.
Because a smaller nucleus implies a higher compaction, which
can affect nuclear functions significantly, it is reasonable to
suggest that arginylation/methylation will have a significant
effect on nuclear function. It also appears likely that arginylationElsevier Ltd All rights reserved
Figure 4. Structures of Some of the Arginylated and Arginylated/Methylated Proteins Identified in This Study
The position of the posttranslationally added Arg or methyl-Arg residues in the represented structures is modeled by incorporating Arg or methyl-Arg in the
primary structure of the protein. Posttranslationally added arginines are marked with green, and the side-chain amino groups are in blue. The methyl groups in
arginine are marked by green spots attached to the blue amino group. Arginylation sites are shown with red arrowheads and arginylation/methylation sites with
blue arrows.
(A) Nucleosome (structures shown are selected from the complex between nucleosome core particle [H3, H4, H2a, H2b] and 146 bp long DNA fragment; PDB
identifier: 1AOI). The position of individual histones (marked on top) and the entire nucleosome assembly (marked ‘‘Nucleosome’’ in the top rightmost panel) are
shown in the topmost panels. The modified sites are located on the DNA binding and histone interaction surfaces likely to affect nucleosome assembly. The
distances between the nitrogen atoms of added Arg or methyl-Arg and the nearest oxygen atoms of phosphate backbone of the DNAmolecule are represented in
the inset images a, b, c, and d and marked by black-dotted lines.
(B) Hsp90 dimer (structure shown is of S. cerevisiae Hsp90; PDB identifier: 2CG9). Modified sites are located on the protein surface and near subunit interaction
sites. Inset images e and f show a detailed image of the modified regions.
(C) U5snRNP-specific protein (structure shown is of a homologous S. cerevisiae protein in complex with rRNA obtained by selecting the relevant structures from
the S. cerevisiae ribosomal 80 s-Eef2-sordarin complex; PDB identifier: 1S1H). Inset image g shows a detailed image of the modified regions.
See also Figure S4 for additional structures. See also Figure S5, Datasets 1 and 2, and Table S2.
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Arginylation Meets Methylationwith subsequent methylation of the added Arg residues can
serve as a second-order regulatory mechanism that could affect
those major metabolic processes in which arginylation and
methylation have been implicated. Methylation may also act to
protect posttranslationally added Arg from chemical modifica-
tions in vivo that could destroy or inactivate them (for example,
by methylglyoxal—a cytotoxic agent linked to disease), in line
with a recently proposed model that methylation acts as a
‘‘guardian’’ of Arg (Fackelmayer, 2005). Finally, methylationChemistry & Biology 18, 1369–137may be necessary to protect proteins against degradation by
the N-end rule pathway, shown to affect some proteins with
Arg in the N-terminal position (Varshavsky, 1997). It appears
likely that the posttranslationally added Arg residues within a
protein that further serve as targets of methylation should be
especially important and/or long lived to allow their further
modification by Arg methyltransferases, an additional level of
regulation or protection of these proteins, and their important
functional sites in vivo.8, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1375
Figure 5. Arginylation Methylation Regulates Nuclear Size
(A) DAPI stained untreated or AMI-1-treated WT and Ate1 KO MEF nucleus.
Scale bar, 25 mm.
(B) Quantification of nuclear size observed in the experiments presented in (A);
the following numbers of nuclei were analyzed: WT, 41; Ate1 KO, 96; WT +
AMI-1, 84; and Ate1 KO + AMI-1, 150. Error bars represent SEM. Star (*)
indicates the p value <0.0001, as determined by Student’s t test.
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Arginylation Meets MethylationSIGNIFICANCE
The current study demonstrates that posttranslationally
added arginines on proteins can be further modified by argi-
nine methylation and that this double posttranslational
modification can regulate DNA arrangement in the chro-
matin and nuclear architecture. This is the first evidence
that posttranslationally modified sites of proteins can
undergo subsequent posttranslational modifications, and
the first functional link between protein arginylation and
Arg methylation, which has been long known to regulate
chromatin and nuclear proteins in vivo. It appears likely
that such double modifications not only increase the
complexity of the signaling through the arginylation and
the methylation pathways but also exert other regulatory
functions through a limited number of protein sites, and1376 Chemistry & Biology 18, 1369–1378, November 23, 2011 ª2011even provide a unique type of protein code. Our study
demonstrated that the interaction of the two important
protein modifications, arginylation and methylation, affects
the nuclear size, suggesting its possible role in nuclear
architecture and function.
EXPERIMENTAL PROCEDURES
Nuclear Fractionation and Nuclear Protein Isolation for Mass
Spectrometry
Cells were lysed in the lysis buffer (0.3 M sucrose, 4 mMMg acetate, 12.5 mM
KCl, 50 mMTris [pH 8.0], 0.5 mM arginine, 1mMDTT, 0.2 mMPMSF, protease
inhibitor cocktail), and nuclear and cytosolic fractions were separated by
centrifugation and further purification of nuclei by centrifugation through
sucrose cushion. Pure nuclei were lysed in 400 mM NaCl-containing lysis
buffer, and the soluble part was collected as nucleosol. The insoluble chro-
matin part was further extracted with 2 M NaCl-containing buffer, and finally
by DNase I treatment (see Supplemental Experimental Procedures for the
detailed procedure). Proteins from each fraction were precipitated by 20%
TCA, and the pellets were analyzed by mass spectrometry.
Mass Spectrometry and Database Searches
Extracts from subcellular fractions of adult mouse heart (cytoplasmic fractions)
and immortalized MEFs (cytoplasmic and nuclear fractions) were used
throughout this study. For the initial identification of arginylation/methylation,
samples obtained during the previous study on the global analysis of protein
arginylation (Wong et al., 2007) were subjected to a new search to detect
the N-terminal mass addition of Arg plus one or two methyl groups as
described below and in Xu et al. (2009). In addition, one protein spot excised
from 2D gel of mouse cardiac actin (Rai et al., 2008) was analyzed. For the
analysis of nuclear proteins, samples were obtained as described above,
and the TCA-precipitated protein pellets were dissolved in Invitrosol
LC/MS Protein Solubilizer following the manufacturer’s protocol (Invitrogen),
reduced and alkylated with 10 mM Tris(2-carboxyethyl)phosphine hydrochlo-
ride (TCEP; Roche Applied Science, Palo Alto, CA, USA) and 55 mM iodoace-
tamide (IAM; Sigma-Aldrich) in 100 mM ammonium bicarbonate. Digestion
was performed in the presence of 50 mM ammonium bicarbonate and 5 mM
calcium chloride (Sigma-Aldrich) using sequencing grade-soluble trypsin
(Promega, Madison, WI, USA). The resulting peptides were extracted by 5%
formic acid, redissolved into buffer A (5% acetonitrile with 0.1% formic
acid), and were pressure loaded onto a reverse-phase (RP) or strong cation
exchange (SCX)/RPMudPIT column and eluted with a linear gradient of aceto-
nitrile or pulses of ammonium acetate salt (5%–100%). Synthetic peptides
were dissolved in water and supplemented with 1% formic acid to the final
concentration of 100 fmol ml1 and analyzed under the same LC-MS/MS
conditions as those used for the digested protein samples. Data-dependent
tandem mass spectrometry (MS/MS) analysis was performed in a LTQ-
Orbitrap mass spectrometer (Thermo Electron, San Jose, CA, USA). Full
mass spectrometry spectra were acquired by the precursor ion scan using
the Orbitrap analyzer with resolution set at 60,000, followed by nine MS/MS
events in the linear ion trap (LTQ), sequentially generated on the first-,
second-, and third-most intense ions selected from the full mass spectrometry
spectrum. Mass spectrometry scan functions and HPLC solvent gradients
were controlled by the Xcalibur data system (Thermo Electron). Tandem
mass spectra were searched against EBI-IPI and NCBI mouse protein data-
bases concatenated with reversed sequences to estimate false-positive
rate, using the ProLuCID (Xu et al., 2006) protein database search algorithm
with peptide mass tolerance of ±3 amu, fragment ion mass tolerance of
0.4 amu, and a static modification of 57.0215 on Cys due to carboxyamidome-
thylation. In order to identify N-terminal arginylated peptides, differential
N-terminal modification searches for a mass addition of Arg (+156.1011)
with an extra mass of either one (+14.0157) or two (+28.0314) methyl groups
were performed with no enzymatic cleavage conditions imposed on the data-
base search. ProLuCID search results were then filtered with DTASelect 2.0
(Tabb et al., 2002) using XCorr and DeltaCN at a false-positive rate of 0.1%
(fp 0.001) estimated by number of reverse hits. Half or fully tryptic (y 1)
peptides only with N-terminal arginylation and Arg methylation (m 0) andElsevier Ltd All rights reserved
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Arginylation Meets Methylationa DeltaMass %5 ppm (DM 5) were accepted; the minimum number of
peptides to identify a protein was set to 1 (p 1). All spectra were verified by
automated filtering and manual filtering against the mass ambiguities shown
in Tables S3 and S4. The final proteins with arginylation modifications that
passed these filtering criteria and manual validation are listed in Tables 1
and 2, and the corresponding mass spectra are shown in Figure 1 and Fig-
ure S1 and Datasets S1 and S2.
In Vivo Methylation Assay
A total of 1.2 million immortalized MEFs were seeded in 100 mm tissue culture
dishes and grown for 15 hr. The plates were washed oncewith 5ml of Met- and
Cys-free DMEM without serum and incubated with 5 ml of the same media for
1 hr 30 min to induce amino acid starvation. After the initial starvation period,
cycloheximide (100 mg/ml) and chloramphenicol (40 mg/ml) (as well as arginine
methyltransferase inhibitor AMI-1 [100 mM] in case of AMI-1 treatment) were
added to the medium, and the incubation was continued for an additional
hour, followed by addition of 30 mCi of L-[methyl-3H]-Methionine (GE Amer-
sham) for a 4 hr incorporation. At the end of the incorporation period, cells
were washed in PBS and harvested by scraping and centrifugation. Cell pellets
were lysed by pipetting in buffer A (50 mM Tris [pH 8], 0.3 M Sucrose, 4 mM
Mg-acetate, 12.5 mM KCl, 10 mM b-ME, 0.5% NP 40, 1 mM DTT, 0.2 mM
PMSF, protease inhibitor cocktail). Nucleus and cytosol were separated using
the protocol adapted from Kaji (1976) by spinning at 4C for 5 min at 20003 g.
The supernatant (cytosol) was collected, and the nuclear pellet was resus-
pended in buffer B (50 mM Tris [pH 7.5], 25 mM KCl, 5 mM MgCl2 0.5% NP
40, 1 mM DTT, 0.2 mM PMSF, protease inhibitor cocktail) and layered onto
an equal volume of 0.88 M sucrose in buffer B, followed by centrifugation at
4C for 5 min at 2000 3 g. The pellet containing pure nuclei was collected
and lysed by pipetting in hypertonic buffer C (50 mM Tris [pH 8.0], 25 mM
KCl, 400 mM NaCl, 1 mM DTT, 0.2 mM PMSF, protease inhibitor cocktail),
followed by centrifugation at 4C for 10 min at 16,000 3 g. The supernatant
was collected as nucleosol and the pellet as chromatin. Protein concentrations
in the cytosol and nucleosol were estimated by the Bradford assay. Protein
concentration in the chromatin fractions was estimated by running known
amounts of nucleosolic proteins and 23 Laemmli buffer-solubilized chromatin
pellets from similar preparations in SDS-PAGE, followed by densitometric
analysis of the whole lane of Coomassie-stained gel. Equal amounts of protein
from cytosol and nucleosol were precipitated by TCA, and incorporation into
the pelleted protein was monitored by liquid scintillation. The chromatin pellet
was washed three times with buffer B, and incorporation was monitored by
liquid scintillation.
In Vivo Arginylation Assay
This assay was performed similar to the in vivo methylation assay, except for
the following changes. Instead of Met- and Cys-free DMEM, custom-made
Arg-free DMEM (Hyclone) was used. A total of 60 mCi of L-[2,3,4-3H] Arginine
(PerkinElmer) was added for 4 hr to each dish containing 5 ml of Arg-free
DMEM without serum. For in vivo arginylation in the absence of translation
inhibitors, the assay was performed in the same way except the cyclohexi-
mide/chloramphenicol treatment step was omitted.
Estimation of Intracellular Methyl-Arg Concentrations in the Protein
and Free Metabolite Pools
Protein fractions prepared as described in the Supplemental Experimental
Procedures were precipitated by 10%TCA, and the supernatant was analyzed
by HPLCwithout acid hydrolysis. The puremethyl arginines (MMA, SDMA, and
ADMA) were used as the standards in HPLC analysis (see Supplemental
Experimental Procedures for standard concentrations). HPLC, amino acid
hydrolysis, and Arg determination were performed by the W.M. Keck Founda-
tion Biotechnology Resource Laboratory at Yale University. See Supplemental
Experimental Procedures for the detailed procedure.
In Vitro Arginylation Assay to Estimate Endogenous ATE1 Activity
in Cellular Fractions
This assay was performed using purified charged Arg-tRNA and protein frac-
tions as the source of Arg-transferase as described in Wang et al. (2011) with
some modifications. Cytosol and nuclei were purified in the same way as
described in the nucleus fractionation section except the pure nuclei wereChemistry & Biology 18, 1369–137lysed by sonication followed by clarification by centrifugation at 16,000 3 g
and used for the assay. After the reaction, protein was precipitated with
10% cold TCA and counted in a liquid scintillation counter (see Supplemental
Experimental Procedures for the detailed procedure).
Estimation of ATE1 Level in Cytosol and Nucleus Fractions
Cells were fractionated in the same way as described in the section ‘‘In Vivo
Methylation Assay.’’ Proteins in the cytosol and nucleosol fractions were
estimated by Bradford assay. Equal amounts of proteins were analyzed by
western blot using an ATE1 rat monoclonal antibody (Wang et al., 2011) to
estimate the difference between the levels of ATE1 in these two fractions.
Estimation of the Nuclear Size
WT or Ate1 KO MEF cells, untreated or treated with 100 mM AMI-1 for 24 hr,
were harvested by trypsinization. Cells were washed once with PBS and fixed
for 20 min with 4% paraformaldehyde in PBS at room temperature. After
fixation, cells were washed three times with PBS, stained with 1 mg/ml DAPI
for 10 min, spotted on polylysine-coated coverslips, and mounted with
Aqua-Poly/Mount (Polysciences, Inc). Five randomly chosen fields from
each preparation were captured at 403 and analyzed using MetaMorph soft-
ware. The pixel area covered by each nucleus was scored as nuclear size
and converted to squared micrometers (mm2) using the MetaMorph internal
calibration tool.
Arginylated and methyl-arginylated protein structure models and the
measurement of distances between arginyl and methylarginyl residues and
the neighboring phosphate atoms of DNA in the histone complexes were
performed using the program Coot (Emsley and Cowtan, 2004). Illustrations
of structures were prepared with the program PyMOL (Schro¨dinger).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables, five figures, two datasets, and
Supplemental Experimental Procedures and can be found with this article on-
line at doi:10.1016/j.chembiol.2011.08.019.
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